Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SBUX | ENB |
|---|---|---|
| Price | $93.53 | $47.38 |
| Change today | ▼ 0.65% | ▼ 0.99% |
| Market cap | $106.62B | $105.59B |
| Return, 3 months | -9.1% | -11.9% |
| Return, year to date | +13.1% | +7.3% |
| Return, 1 year | +13.8% | +6.2% |
| P/E (TTM) | 54.1 | 25.7 |
| P/B | -13.9 | 2.5 |
| P/E percentile vs own 5y | 87th | 75th |
| Dividend yield | 2.64% | 5.69% |
| Revenue growth (YoY, latest qtr) | -1.4% | +97.1% |
| Net profit growth (YoY) | +87.1% | -32.4% |
| Gross margin | 22.1% | 25.7% |
| Operating margin | 10.1% | 13.6% |
| Net margin | 5.2% | 6.8% |
| Return on equity | – | 9.7% |
| Analyst target vs. price | +27.2% | +21.7% |
| Analyst buy share | 63% | 57% |
| RSI (14) | 26 | 38 |
| 30-day volatility | 20.5% | 19.0% |
| Max drawdown, 1 year | -14.5% | -15.4% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.